NASDAQ NMS - GLOBAL MARKET · AURA
+0.39% · +$0.0300 · Vol 500.9K
Market closed · last close 4:00 PM ET · price as of 16:01:27 ET
Aura Biosciences Inc

Aura Biosciences Inc

Biotechnology
$7.80
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
AURA
Aura Biosciences Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AURA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AURA catalysts
About Aura Biosciences Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
113
Country
US

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.77
Day high
$8.09
Day low
$7.65
Previous close
$7.77
52W high
$8.90
-12.36% from high
52W low
$4.97
72% of range
Market cap
$808.9M
EPS
$-1.9300
Beta
-0.09
Shares out
103.7M
Volume
500.9K
0.80× rel vol
Avg volume
626.8K
VWAP
$7.83
Price history computed in-house
1W
+1.56%
1M
+10.64%
3M
+2.50%
1Y
+19.08%
YTD
+43.12%
SMA 50 $7.14 · above
SMA 200 $6.50 · above
52W position 72%

AURA overview

Veridion Score
59
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AURA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AURA Form 4 filings
Public disclosures

Congress activity in AURA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AURA in the cached public ledger.

Federal contracts

AURA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AURA in this window.
Lobbying spend

AURA lobbying filings, year to date.

Registered lobbying filings matched to Aura Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AURA in this window.
Loading news for AURA
Analyst ratings
Sovereign unlock shows live analyst consensus for AURA.
Options
Sovereign unlock shows live options positioning for AURA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.